Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Pharmacological treatment of schizophrenia.

Leucht S, Heres S, Kissling W, Davis JM.

Fortschr Neurol Psychiatr. 2013 May;81(5):e1-13. doi: 10.1055/s-0033-1335405. Epub 2013 May 23. Review.

PMID:
23702802
2.

Evidence-based pharmacotherapy of schizophrenia.

Leucht S, Heres S, Kissling W, Davis JM.

Int J Neuropsychopharmacol. 2011 Mar;14(2):269-84. doi: 10.1017/S1461145710001380. Epub 2011 Jan 6. Review.

PMID:
21208500
3.
4.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients..

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

5.

Strategies for enhancing drug therapy of schizophrenia.

Schooler NR, Levine J.

Am J Psychother. 1983 Oct;37(4):521-32. Review.

PMID:
6140869
6.

[Managing agitation in acute psychotic episodes of schizophrenia].

Thomas P.

Encephale. 2006 Jan;32 Pt 2:S12-3. French. No abstract available.

PMID:
16800080
7.

Pharmacological management of acutely agitated schizophrenic patients.

San L, Arranz B, Escobar R.

Curr Pharm Des. 2005;11(19):2471-7. Review.

PMID:
16026300
8.

Intramuscular aripiprazole in the control of agitation.

Currier GW, Citrome LL, Zimbroff DL, Oren D, Manos G, McQuade R, Pikalov AA 3rd, Crandall DT.

J Psychiatr Pract. 2007 May;13(3):159-69.

PMID:
17522559
9.

Management strategies for the treatment of schizophrenia.

Kane JM.

J Clin Psychiatry. 1999;60 Suppl 12:13-7. Review.

10.

Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German Research Network on Schizophrenia.

Gaebel W, Riesbeck M, Wölwer W, Klimke A, Eickhoff M, von Wilmsdorff M, Jockers-Scherübl MC, Kühn KU, Lemke M, Bechdolf A, Bender S, Degner D, Schlösser R, Schmidt LG, Schmitt A, Jäger M, Buchkremer G, Falkai P, Klingberg S, Köpcke W, Maier W, Häfner H, Ohmann C, Salize HJ, Schneider F, Möller HJ; German Study Group on First-Episode Schizophrenia..

J Clin Psychiatry. 2007 Nov;68(11):1763-74.

PMID:
18052570
11.

The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.

Kane JM, Leucht S, Carpenter D, Docherty JP; Expert Consensus Panel for Optimizing Pharmacologic Treatment of Psychotic Disorders..

J Clin Psychiatry. 2003;64 Suppl 12:5-19.

12.

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders.

Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for the Treatment of Schizophrenia and Related Disorders..

Aust N Z J Psychiatry. 2005 Jan-Feb;39(1-2):1-30. Review.

PMID:
15660702
13.

[Initial use of risperidone in the treatment of acutely exacerbated schizophrenic patients--an interim analysis].

Pajonk FG, Schreiner A, Peters S, Rettig K, Degner D, Rüther E.

Fortschr Neurol Psychiatr. 2003 May;71(5):249-54. German.

PMID:
12740756
14.

Management of patients presenting with acute psychotic episodes of schizophrenia.

Thomas P, Alptekin K, Gheorghe M, Mauri M, Olivares JM, Riedel M.

CNS Drugs. 2009;23(3):193-212. doi: 10.2165/00023210-200923030-00002. Review.

PMID:
19320529
15.

A post hoc analysis of the impact on hostility and agitation of quetiapine and haloperidol among patients with schizophrenia.

Chengappa KN, Goldstein JM, Greenwood M, John V, Levine J.

Clin Ther. 2003 Feb;25(2):530-41.

PMID:
12749512
16.

[Antipsychotic agents: what do meta analyses say?].

Millet B.

Encephale. 2007 Jun;33 Pt 3:S419-24. doi: 10.1016/S0013-7006(07)74594-3. French. No abstract available.

PMID:
19101363
17.

[Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].

Lévy-Rueff M, Jurgens A, Lôo H, Olié JP, Amado I.

Encephale. 2008 Oct;34(5):526-33. doi: 10.1016/j.encep.2007.08.008. Epub 2008 Jan 11. French.

PMID:
19068343
18.

Efficacy of topiramate, valproate, and their combination on aggression/agitation behavior in patients with psychosis.

Gobbi G, Gaudreau PO, Leblanc N.

J Clin Psychopharmacol. 2006 Oct;26(5):467-73.

PMID:
16974186
19.

Treatment of agitation in patients with schizophrenia.

Marder SR.

J Clin Psychiatry. 2008 Jun;69(6):e17.

20.

Important issues in the drug treatment of schizophrenia.

Davis JM, Schaffer CB, Killian GA, Kinard C, Chan C.

Schizophr Bull. 1980;6(1):70-87.

PMID:
6102795

Supplemental Content

Support Center